Bruker Announces the Designation and Certification of its RAID-M Handheld Chemical Detector Under the SAFETY ACT as an Approved

Bruker Daltonics NBC Detection Corp., an operating
company of Bruker BioSciences Corporation (NASDAQ: BRKR), today
announces that the Department of Homeland Security has granted
Designation and Certification of the RAID-M as an approved product
under the Support Anti-terrorism by Fostering Effective Technologies
Act of 2002 (the SAFETY Act). The RAID-M received both Designation as
a Qualified Anti-Terrorism Technology and Certification as an Approved
Product for Homeland Security. This is the culmination of a vigorous
and meticulous evaluation of the efficacy of the RAID-M that took
several months.
   Frank Thibodeau, Vice President, commented: "This Certification by
the Department of Homeland Security is more evidence that the RAID-M
is considered by many to be the best handheld chemical detector in the
world today. It is really a great tool in the hands of our country's
first responders. Along with many independent tests by government
agencies around the world, the DHS Certification lends even more
credibility and confidence in the RAID-M as the premier chemical and
toxic industrial detector on the market."
   By receiving the Designation and Certification, Bruker Daltonics,
its customers and its suppliers will enjoy significant product
liability protections under the Safety Act.

   ABOUT BRUKER BIOSCIENCES

   Bruker BioSciences, headquartered in Billerica, Massachusetts, is
the publicly traded parent company of Bruker Daltonics Inc. and Bruker
AXS Inc. Bruker Daltonics is a leading developer and provider of
innovative life science tools based on mass spectrometry. Bruker AXS
is a leading developer and provider of life science and advanced
materials research tools based on X-ray technology. For more
information about Bruker BioSciences Corporation, please visit
www.bruker-biosciences.com

   CAUTIONARY STATEMENT

   Any statements contained in this press release that do not
describe historical facts may constitute forward-looking statements as
that term is defined in the Private Securities Litigation Reform Act
of 1995. Any forward-looking statements contained herein are based on
current expectations, but are subject to a number of risks and
uncertainties. The factors that could cause actual future results to
differ materially from current expectations include, but are not
limited to, risks and uncertainties relating to the companies'
reorganization strategies, integration risks, failure of conditions,
technological approaches, product development, market acceptance, cost
and pricing of the companies' products, changes in governmental
regulations, capital spending and government funding policies, FDA and
other regulatory approvals to the extent applicable, competition, the
intellectual property of others, patent protection and litigation.
These and other factors are identified and described in more detail in
our filings with the SEC, including, without limitation, our
respective annual reports on Form 10-K for the year ended December 31,
2004, our most recent quarterly reports on Form 10-Q, our current
reports on Form 8-K and the joint proxy statement/prospectus filed in
connection with the merger. We disclaim any intent or obligation to
update these forward-looking statements.